Safety and effectiveness of once-daily Hysingla extended-release tablets in patients with baseline depression or anxiety. | Pain Manag;7(6): 473-488, 2017 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Safety and effectiveness of once-daily Hysingla extended-release tablets in patients with baseline depression or anxiety.

Taber, Louise; He, Ellie; Ripa, Steven R.

Affiliation

Taber L; Arizona Research Center, Phoenix, AZ 85023, USA.
He E; Purdue Pharma LP, Stamford, CT 06901, USA.
Ripa SR; Purdue Pharma LP, Stamford, CT 06901, USA.

Pain Manag ; 7(6): 473-488, 2017 Nov.

Article in En | MEDLINE | ID: mdl-28747087

Subject(s)
Key words

anxiety; chronic pain; depression; hydrocodone bitartrate; long-term opioid therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety / Depression / Chronic Pain / Hydrocodone / Analgesics, Opioid Limits: Female / Humans / Male / Middle aged Language: En Journal: Pain Manag Year: 2017 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety / Depression / Chronic Pain / Hydrocodone / Analgesics, Opioid Limits: Female / Humans / Male / Middle aged Language: En Journal: Pain Manag Year: 2017 Document type: Article Affiliation country: Country of publication: